About this trial
Obsessive-compulsive disorder (OCD) and anxiety disorders are common and debilitating conditions which are often chronic when treatment is not provided. International guidelines recommend cognitive behavioral therapy (CBT) as the first-line treatment, and research has shown that CBT can be delivered over a concentrated period of time. The Bergen 4-Day Treatment (B4DT) is an exposure-based treatment which is delivered over four consecutive days. B4DT has been shown to induce rapid and long-lasting remission in around 70% of patients. This provides a platform for studying psychological and neurobiological changes associated with treatment response and non-response. The present study will investigate longitudinal changes in psychological measures and DNA methylation in patients who receive the B4DT, as well as a subset will also undergo multimodal brain imaging.
Eligibility criteria
Qualifiers
Diagnosed with obsessive-compulsive disorder, panic disorder or social anxiety disorder using DSM-5 criteria
Referred to National Clinic for 4-Day Treatment, Haukeland University Hospital, Bergen, Norway
Consented to participate in the "Kvalitetsregister for konsentrerte behandlingsformat"
Disqualifiers
Suicidal, ongoing mania, primary eating disorder, intellectual disability, ongoing psychosis, ongoing substance abuse
Trial design
Treatments tested in this trial
- Bergen 4-Day Treatment (B4DT)
Treatment groups
Sponsors and collaborators
Haukeland University Hospital
Lead sponsor
University of Oslo
Collaborator
Amsterdam UMC, location VUmc
Collaborator
University of North Carolina, Chapel Hill
Collaborator
Harvard Medical School (HMS and HSDM)
Collaborator
University of Bergen
Collaborator
Oslo University Hospital
Collaborator